{"entity":{"type":"insider","cik":"0001519692","url":"/insider/0001519692","json_url":"/insider/0001519692.json","name":"Greenstein Leonard M.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":17,"n_filings":12,"first":"2013-05-28","last":"2023-04-21","span_basis":"filed_date"},"name_variants":[{"name":"Greenstein Leonard M.","source":"filing","n_filings":12,"first_seen":"2013-05-28","last_seen":"2023-04-21"}],"transactions":[{"id":8038186,"accession":"0001519692-23-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001519692-23-000012","line_url":"/filing/0001519692-23-000012#line-1","is_derivative":false,"issuer_cik":"0001519692","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001519692","owner_cik":"0001519692","owner_name":"Greenstein Leonard M.","owner_display_name":"Greenstein Leonard M.","owner_url":"/insider/0001519692","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":14.02,"price_display":"14.02","price_state":"stated","total_value":70100.0,"total_display":"70,100.00","total_whole":"70,100","shares_owned_after":26785.0,"shares_owned_after_display":"26,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-20","filed_date":"2023-04-21","scope":"insider"},{"id":8006803,"accession":"0001519692-23-000010","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001519692-23-000010","line_url":"/filing/0001519692-23-000010#line-3","is_derivative":false,"issuer_cik":"0001519692","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001519692","owner_cik":"0001519692","owner_name":"Greenstein Leonard M.","owner_display_name":"Greenstein Leonard M.","owner_url":"/insider/0001519692","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":346.0,"shares_display":"346","price_per_share":12.15,"price_display":"12.15","price_state":"stated","total_value":4203.9,"total_display":"4,203.90","total_whole":"4,204","shares_owned_after":31785.0,"shares_owned_after_display":"31,785","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-23","filed_date":"2023-03-23","scope":"insider"},{"id":8006802,"accession":"0001519692-23-000010","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001519692-23-000010","line_url":"/filing/0001519692-23-000010#line-2","is_derivative":false,"issuer_cik":"0001519692","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001519692","owner_cik":"0001519692","owner_name":"Greenstein Leonard M.","owner_display_name":"Greenstein Leonard M.","owner_url":"/insider/0001519692","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":332.0,"shares_display":"332","price_per_share":12.64,"price_display":"12.64","price_state":"stated","total_value":4196.48,"total_display":"4,196.48","total_whole":"4,196","shares_owned_after":32131.0,"shares_owned_after_display":"32,131","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-22","filed_date":"2023-03-23","scope":"insider"},{"id":8006801,"accession":"0001519692-23-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001519692-23-000010","line_url":"/filing/0001519692-23-000010#line-1","is_derivative":false,"issuer_cik":"0001519692","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001519692","owner_cik":"0001519692","owner_name":"Greenstein Leonard M.","owner_display_name":"Greenstein Leonard M.","owner_url":"/insider/0001519692","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":326.0,"shares_display":"326","price_per_share":12.89,"price_display":"12.89","price_state":"stated","total_value":4202.14,"total_display":"4,202.14","total_whole":"4,202","shares_owned_after":32463.0,"shares_owned_after_display":"32,463","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-21","filed_date":"2023-03-23","scope":"insider"},{"id":7943432,"accession":"0001519692-23-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001519692-23-000008","line_url":"/filing/0001519692-23-000008#line-2","is_derivative":false,"issuer_cik":"0001519692","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001519692","owner_cik":"0001519692","owner_name":"Greenstein Leonard M.","owner_display_name":"Greenstein Leonard M.","owner_url":"/insider/0001519692","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":333.0,"shares_display":"333","price_per_share":12.61,"price_display":"12.61","price_state":"stated","total_value":4199.13,"total_display":"4,199.13","total_whole":"4,199","shares_owned_after":32789.0,"shares_owned_after_display":"32,789","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-20","filed_date":"2023-03-21","scope":"insider"},{"id":7943429,"accession":"0001519692-23-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001519692-23-000008","line_url":"/filing/0001519692-23-000008#line-1","is_derivative":false,"issuer_cik":"0001519692","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001519692","owner_cik":"0001519692","owner_name":"Greenstein Leonard M.","owner_display_name":"Greenstein Leonard M.","owner_url":"/insider/0001519692","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":316.0,"shares_display":"316","price_per_share":13.28,"price_display":"13.28","price_state":"stated","total_value":4196.48,"total_display":"4,196.48","total_whole":"4,196","shares_owned_after":33122.0,"shares_owned_after_display":"33,122","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-17","filed_date":"2023-03-21","scope":"insider"},{"id":8006800,"accession":"0001519692-23-000006","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001519692-23-000006","line_url":"/filing/0001519692-23-000006","is_derivative":false,"issuer_cik":"0001519692","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001519692","owner_cik":"0001519692","owner_name":"Greenstein Leonard M.","owner_display_name":"Greenstein Leonard M.","owner_url":"/insider/0001519692","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5313.0,"shares_display":"5,313","price_per_share":13.439410878976096,"price_display":"13.44","price_state":"stated","total_value":71403.59,"total_display":"71,403.59","total_whole":"71,404","shares_owned_after":33438.0,"shares_owned_after_display":"33,438","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-16","filed_date":"2023-03-17","scope":"insider","n_lines":2},{"id":8713199,"accession":"0001519692-23-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001519692-23-000004","line_url":"/filing/0001519692-23-000004#line-1","is_derivative":false,"issuer_cik":"0001519692","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001519692","owner_cik":"0001519692","owner_name":"Greenstein Leonard M.","owner_display_name":"Greenstein Leonard M.","owner_url":"/insider/0001519692","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.12,"price_display":"15.12","price_state":"stated","total_value":75600.0,"total_display":"75,600.00","total_whole":"75,600","shares_owned_after":34289.0,"shares_owned_after_display":"34,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-16","filed_date":"2023-02-17","scope":"insider"},{"id":8006797,"accession":"0001519692-23-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001519692-23-000002","line_url":"/filing/0001519692-23-000002#line-1","is_derivative":false,"issuer_cik":"0001519692","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001519692","owner_cik":"0001519692","owner_name":"Greenstein Leonard M.","owner_display_name":"Greenstein Leonard M.","owner_url":"/insider/0001519692","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":14.56,"price_display":"14.56","price_state":"stated","total_value":72800.0,"total_display":"72,800.00","total_whole":"72,800","shares_owned_after":39289.0,"shares_owned_after_display":"39,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-19","filed_date":"2023-01-20","scope":"insider"},{"id":6131735,"accession":"0001519692-22-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001519692-22-000012","line_url":"/filing/0001519692-22-000012#line-1","is_derivative":false,"issuer_cik":"0001519692","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001519692","owner_cik":"0001519692","owner_name":"Greenstein Leonard M.","owner_display_name":"Greenstein Leonard M.","owner_url":"/insider/0001519692","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":14.64,"price_display":"14.64","price_state":"stated","total_value":73200.0,"total_display":"73,200.00","total_whole":"73,200","shares_owned_after":44289.0,"shares_owned_after_display":"44,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2022-12-16","scope":"insider"},{"id":6654656,"accession":"0001519692-22-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001519692-22-000010","line_url":"/filing/0001519692-22-000010#line-1","is_derivative":false,"issuer_cik":"0001519692","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001519692","owner_cik":"0001519692","owner_name":"Greenstein Leonard M.","owner_display_name":"Greenstein Leonard M.","owner_url":"/insider/0001519692","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":16.54,"price_display":"16.54","price_state":"stated","total_value":82700.0,"total_display":"82,700.00","total_whole":"82,700","shares_owned_after":49289.0,"shares_owned_after_display":"49,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-17","filed_date":"2022-11-18","scope":"insider"},{"id":6571482,"accession":"0001519692-22-000008","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001519692-22-000008","line_url":"/filing/0001519692-22-000008","is_derivative":false,"issuer_cik":"0001519692","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001519692","owner_cik":"0001519692","owner_name":"Greenstein Leonard M.","owner_display_name":"Greenstein Leonard M.","owner_url":"/insider/0001519692","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.917712,"price_display":"15.92","price_state":"stated","total_value":79588.56,"total_display":"79,588.56","total_whole":"79,589","shares_owned_after":54412.0,"shares_owned_after_display":"54,412","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-20","filed_date":"2022-10-28","scope":"insider","n_lines":2},{"id":6571476,"accession":"0001519692-22-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001519692-22-000006","line_url":"/filing/0001519692-22-000006#line-1","is_derivative":false,"issuer_cik":"0001519692","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001519692","owner_cik":"0001519692","owner_name":"Greenstein Leonard M.","owner_display_name":"Greenstein Leonard M.","owner_url":"/insider/0001519692","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":16.03,"price_display":"16.03","price_state":"stated","total_value":80150.0,"total_display":"80,150.00","total_whole":"80,150","shares_owned_after":59289.0,"shares_owned_after_display":"59,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-15","filed_date":"2022-09-16","scope":"insider"},{"id":6936665,"accession":"0001519692-22-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001519692-22-000004","line_url":"/filing/0001519692-22-000004#line-1","is_derivative":false,"issuer_cik":"0001519692","issuer_name":"Tarsus Pharmaceuticals, Inc.","issuer_ticker":"TARS","issuer_name_source":null,"issuer_url":"/issuer/0001519692","owner_cik":"0001519692","owner_name":"Greenstein Leonard M.","owner_display_name":"Greenstein Leonard M.","owner_url":"/insider/0001519692","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":16.3,"price_display":"16.30","price_state":"stated","total_value":81500.0,"total_display":"81,500.00","total_whole":"81,500","shares_owned_after":64289.0,"shares_owned_after_display":"64,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-18","filed_date":"2022-08-19","scope":"insider"},{"id":4702076,"accession":"0001209191-13-028995","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-028995","line_url":"/filing/0001209191-13-028995#line-1","is_derivative":false,"issuer_cik":"0001013606","issuer_name":"ENDOLOGIX INC /DE/","issuer_ticker":"ELGX","issuer_name_source":null,"issuer_url":"/issuer/0001013606","owner_cik":"0001519692","owner_name":"Greenstein Leonard M.","owner_display_name":"Greenstein Leonard M.","owner_url":"/insider/0001519692","role":"Officer (VP Finance & Corp Controller)","role_mark":"O","role_mark_label":"Officer (VP Finance & Corp Controller)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Finance & Corp Controller","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1253.0,"shares_display":"1,253","price_per_share":14.01,"price_display":"14.01","price_state":"stated","total_value":17554.53,"total_display":"17,554.53","total_whole":"17,555","shares_owned_after":16445.0,"shares_owned_after_display":"16,445","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-05-28","filed_date":"2013-05-28","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":17,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":17,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":17},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001819790","name":"Tarsus Pharmaceuticals, Inc.","url":"/issuer/0001819790","role":"Officer (Chief Financial Officer)","n_filings":11,"first_seen":"2022-08-19","last_seen":"2023-04-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001013606","name":"ENDOLOGIX INC /DE/","url":"/issuer/0001013606","role":"Officer (VP Finance & Corp Controller)","n_filings":1,"first_seen":"2013-05-28","last_seen":"2013-05-28"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001519692","retrieved_at":"2026-08-27T03:01:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}